companyMessage from the President & Representative Director

Our new journey as ArkMS Co., Ltd. has been embarked on being a member of Alfresa Group with the trust and achievements we’ve proudly built up in running the business as a Japanese CRO over 30 years. We greatly appreciate the tremendous support we’ve received over the course of decades from our clients including pharmaceutical companies as well as system and database associated providers. We’re determined to keep striving to meet the clients’ highest expectations by further cultivating trust with them.

We’ll also continue pursuing innovations in the medical field without being satisfied about the present. As a team of professionals, our domain of service extends from the current post-marketing survey, clinical development, clinical research and RWD business to a field of prevention and treatment that employs apps, digital therapeutics, medical devices and regenerative medicine to offer optimum solutions to clients. Our challenge in pursuing and applying innovative approaches such as generating data-driven evidences and precision medicine that are strongly desired at the frontline of medical care in this ever-evolving medical and healthcare industry will never stop.

“Making a new start and contributing to society”
We’ll take a vital step forward to the future as a member of Alfresa Group while integrating its extensive network and abundant resources with a trust between us to further strengthen our capability of providing healthcare solutions. I’m confident this enables us to keep accommodating diversified needs of our clients swiftly and flexibly. Our endeavor to better serve the development of healthcare and tackle social challenges will be made to achieve a healthier world. Your continued support for our journey is greatly appreciated as we move forward with our new challenges.

Again, I sincerely value your continuing patronage and business.

President and Representative Director
MIZUO Akira